__timestamp | Merus N.V. | Walgreens Boots Alliance, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 3852327 | 17691000000 |
Thursday, January 1, 2015 | 839656 | 21669000000 |
Friday, January 1, 2016 | 4478145 | 23425000000 |
Sunday, January 1, 2017 | 16432324 | 23618000000 |
Monday, January 1, 2018 | 11890871 | 24638000000 |
Tuesday, January 1, 2019 | 34110000 | 23183000000 |
Wednesday, January 1, 2020 | 35781000 | 22836000000 |
Friday, January 1, 2021 | 40896000 | 23798000000 |
Saturday, January 1, 2022 | 52200000 | 24994000000 |
Sunday, January 1, 2023 | 59836000 | 25479000000 |
Monday, January 1, 2024 | 28113000000 |
In pursuit of knowledge
In the ever-evolving landscape of corporate finance, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Walgreens Boots Alliance, Inc., a global leader in retail pharmacy, and Merus N.V., a clinical-stage immuno-oncology company, present a fascinating study in contrasts. From 2014 to 2023, Walgreens consistently reported SG&A expenses in the range of $17.7 billion to $25.5 billion, reflecting its expansive operations. In contrast, Merus N.V.'s SG&A expenses grew from a modest $3.9 million to $59.8 million, showcasing a significant growth trajectory. This disparity highlights the different scales and operational strategies of these companies. While Walgreens' expenses are indicative of its vast retail network, Merus' increasing expenses suggest a strategic investment in growth and innovation. Notably, 2024 data for Merus is missing, leaving room for speculation on its future financial strategies.
Johnson & Johnson or Merus N.V.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Novartis AG vs Walgreens Boots Alliance, Inc.
Operational Costs Compared: SG&A Analysis of Incyte Corporation and Merus N.V.
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Merus N.V. Trends and Insights
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Walgreens Boots Alliance, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Perrigo Company plc
PTC Therapeutics, Inc. vs Merus N.V.: SG&A Expense Trends
Merus N.V. vs Soleno Therapeutics, Inc.: SG&A Expense Trends